Dylan C. Dean

1.5k total citations
24 papers, 963 citations indexed

About

Dylan C. Dean is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Dylan C. Dean has authored 24 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Dylan C. Dean's work include Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Cancer-related Molecular Pathways (5 papers). Dylan C. Dean is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Cancer-related Molecular Pathways (5 papers). Dylan C. Dean collaborates with scholars based in United States, China and Thailand. Dylan C. Dean's co-authors include Francis J. Hornicek, Zhenfeng Duan, Huirong Shi, Pichaya Thanindratarn, Zhenfeng Duan, Wenlong Feng, Scott D. Nelson, Jinglu Wang, Shen Shen and Juncheng Cui and has published in prestigious journals such as The FASEB Journal, Clinical Orthopaedics and Related Research and Molecular Cancer.

In The Last Decade

Dylan C. Dean

23 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dylan C. Dean United States 14 555 347 307 285 185 24 963
Sajida Piperdi United States 17 410 0.7× 222 0.6× 464 1.5× 521 1.8× 252 1.4× 25 1.1k
Hanli Fan United States 12 318 0.6× 243 0.7× 320 1.0× 195 0.7× 210 1.1× 16 931
Michele Iuliani Italy 18 350 0.6× 271 0.8× 285 0.9× 429 1.5× 146 0.8× 39 947
David Pook Australia 14 309 0.6× 217 0.6× 631 2.1× 454 1.6× 231 1.2× 60 976
Joseph L. Sottnik United States 17 342 0.6× 163 0.5× 264 0.9× 341 1.2× 105 0.6× 26 837
Bizhan Bandarchi Canada 14 440 0.8× 214 0.6× 202 0.7× 422 1.5× 101 0.5× 19 929
Shu-Fang Jia United States 15 532 1.0× 175 0.5× 299 1.0× 283 1.0× 127 0.7× 19 845
Stephen B. Keysar United States 15 580 1.0× 261 0.8× 270 0.9× 560 2.0× 117 0.6× 31 1.1k
Simona Principe Canada 10 668 1.2× 388 1.1× 111 0.4× 154 0.5× 193 1.0× 10 979
Philippe Pujuguet Belgium 16 542 1.0× 153 0.4× 140 0.5× 446 1.6× 112 0.6× 22 1.1k

Countries citing papers authored by Dylan C. Dean

Since Specialization
Citations

This map shows the geographic impact of Dylan C. Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan C. Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan C. Dean more than expected).

Fields of papers citing papers by Dylan C. Dean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dylan C. Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan C. Dean. The network helps show where Dylan C. Dean may publish in the future.

Co-authorship network of co-authors of Dylan C. Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Dylan C. Dean. A scholar is included among the top collaborators of Dylan C. Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dylan C. Dean. Dylan C. Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dean, Dylan C., Wenlong Feng, Robert L. Walker, et al.. (2023). Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study. Clinical Orthopaedics and Related Research. 481(11). 2140–2153. 2 indexed citations
2.
Li, Xiaoyang, Dylan C. Dean, Jin Yuan, et al.. (2022). Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma. Biomedicine & Pharmacotherapy. 149. 112888–112888. 4 indexed citations
3.
Cui, Juncheng, Dylan C. Dean, Francis J. Hornicek, et al.. (2022). ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage.. PubMed. 12(4). 1577–1592. 5 indexed citations
4.
Thanindratarn, Pichaya, Ran Wei, Dylan C. Dean, et al.. (2021). Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma. Molecular Oncology. 15(12). 3721–3737. 9 indexed citations
5.
Li, Xiaoyang, Dylan C. Dean, Scott D. Nelson, et al.. (2021). Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2. Cancer Control. 28. 2895463322–2895463322. 2 indexed citations
6.
Thanindratarn, Pichaya, Dylan C. Dean, Wenlong Feng, et al.. (2020). Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value. European Spine Journal. 29(12). 3214–3228. 11 indexed citations
7.
Dean, Dylan C., et al.. (2020). Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy. Cancer Letters. 474. 158–167. 65 indexed citations
8.
Cui, Juncheng, Dylan C. Dean, Francis J. Hornicek, Zhiwei Chen, & Zhenfeng Duan. (2020). The role of extracelluar matrix in osteosarcoma progression and metastasis. Journal of Experimental & Clinical Cancer Research. 39(1). 178–178. 102 indexed citations
9.
Thanindratarn, Pichaya, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek, & Zhenfeng Duan. (2020). T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma. Cell Proliferation. 53(10). e12901–e12901. 10 indexed citations
10.
Wei, Ran, Dylan C. Dean, Pichaya Thanindratarn, et al.. (2020). Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study. Frontiers in Oncology. 10. 3 indexed citations
11.
Wei, Ran, Pichaya Thanindratarn, Dylan C. Dean, et al.. (2020). Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma. Journal of Orthopaedic Research®. 38(9). 1952–1964. 23 indexed citations
12.
Shen, Shen, Dylan C. Dean, Zujiang Yu, & Zhenfeng Duan. (2019). Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway. Hepatology Research. 49(10). 1097–1108. 40 indexed citations
13.
Feng, Wenlong, Dylan C. Dean, Francis J. Hornicek, Huirong Shi, & Zhenfeng Duan. (2019). Exosomes promote pre-metastatic niche formation in ovarian cancer. Molecular Cancer. 18(1). 124–124. 221 indexed citations
14.
Thanindratarn, Pichaya, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek, & Zhenfeng Duan. (2019). Advances in immune checkpoint inhibitors for bone sarcoma therapy. Journal of bone oncology. 15. 100221–100221. 123 indexed citations
15.
Thanindratarn, Pichaya, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek, & Zhenfeng Duan. (2019). Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications. Cancer Treatment Reviews. 82. 101934–101934. 52 indexed citations
16.
Wei, Ran, Dylan C. Dean, Pichaya Thanindratarn, et al.. (2019). Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application. Cancer Letters. 479. 54–60. 35 indexed citations
17.
Wang, Jinglu, Dylan C. Dean, Francis J. Hornicek, Huirong Shi, & Zhenfeng Duan. (2019). Cyclin‐dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer. The FASEB Journal. 33(5). 5990–6000. 50 indexed citations
18.
Shen, Shen, Dylan C. Dean, Zujiang Yu, et al.. (2019). Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067. Journal of Cancer. 11(1). 132–141. 18 indexed citations
19.
Dean, Dylan C., Shen Shen, Francis J. Hornicek, & Zhenfeng Duan. (2018). From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma. Cancer and Metastasis Reviews. 37(4). 719–731. 57 indexed citations
20.
Wang, Jinglu, Dylan C. Dean, Francis J. Hornicek, Shi Huirong, & Zhenfeng Duan. (2018). RNA sequencing (RNA-Seq) and its application in ovarian cancer. Gynecologic Oncology. 152(1). 194–201. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sajida Piperdi Breakdown of academic impact, for papers by Hanli Fan Breakdown of academic impact, for papers by Michele Iuliani Breakdown of academic impact, for papers by David Pook Breakdown of academic impact, for papers by Joseph L. Sottnik Breakdown of academic impact, for papers by Bizhan Bandarchi Breakdown of academic impact, for papers by Shu-Fang Jia Breakdown of academic impact, for papers by Stephen B. Keysar Breakdown of academic impact, for papers by Simona Principe Breakdown of academic impact, for papers by Philippe Pujuguet
Rankless by CCL
2026